WI
Windtree Therapeutics, Inc.
WINT · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $10.1K
P/E Ratio -
Div. Yield -
ROE 1,302.82%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.11x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 37.97%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 387.78%
FCF margin 16,801.10%
Net margin 44,447.80%
Quality
0 /100
Poor ROIC 455.49%
Asset turnover 0.01x
ROE 1,302.82%
Debt
0 /100
High Current ratio 0.33x
Int. coverage -88.14x
Debt/Equity N/A
Stability
44 /100
Moderate Beta 1.60x
Profitable years 0
EPS volatility 23.45%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na WINT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jed A. Latkin
Employees
14
Headquarters
Warrington
Nadcházející události
26 LIS
Earnings
Upcoming earnings report